Lansoprazole, Amoxicillin, Clarithromycin Kit
Product Images NDC 57237-001

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole, Amoxicillin, Clarithromycin (NDC 57237-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Amoxicillin Clarithromycin Carton

This is a description of a medication called Rising® NDC 57237-001-14, which is a triple therapy intended for use in the eradication of H. pylori or prevention of duodenal ulcer recurrence. The medication pack includes Lansoprazole Delayed-Release Capsules USP, Amoxicillin Capsules USP, and Clarithromycin Tablets USP. It features 14 daily patient cards and child-resistant packaging for protection. The items should not be used separately or for other purposes than the intended use. The medication should be kept out of reach of children and stored in a cool place. Proper use information can be found in the package insert. Manufacturing information is also provided.*

FDA Label Image

Lansoprazole-amoxicillin-clarithromycin-structure-1 (Lansoprazole Amoxicillin Clarithromycin Structure 1)

FDA Label Image

Lansoprazole-amoxicillin-clarithromycin-structure-2 (Lansoprazole Amoxicillin Clarithromycin Structure 2)

FDA Label Image

Lansoprazole-amoxicillin-clarithromycin-structure-3 (Lansoprazole Amoxicillin Clarithromycin Structure 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.